Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

351
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
351
Drug Regulation01:25

Drug Regulation

1.5K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.5K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

203
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
203
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

304
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
304
Drug Classes and Categories01:25

Drug Classes and Categories

2.1K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.1K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

1.3K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Picture this! Use of comics to orient learners to bedside rounding.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

Raising the bar on surgical site infection bundles: Preoperative penicillin allergy testing in gynecologic oncology patients with a reported penicillin allergy - A quality improvement study.

Gynecologic oncology·2026
Same author

Cross-Sectional Analysis of Contextual Factors Associated With Sexual Violence Against Children and Youth in Low- and Middle-Income Countries.

Journal of interpersonal violence·2026
Same author

PTQ10:L8-BO organic photoactive layers enable improved stability for solar water oxidation and enhanced unassisted water splitting.

EES solar·2026
Same author

Prevalence of Nonfatal Opioid Overdoses and Interactions With the Health Care System Prior to Death Among Opioid Overdose Decedents, Rhode Island, 2023.

Public health reports (Washington, D.C. : 1974)·2026
Same author

Nanoparticle-Mediated Interface Engineering for Uniform, Reproducible Electron Transport Layers in Scalable Perovskite Solar Cells.

ACS applied materials & interfaces·2026
Same journal

1776: Medical Care During the Revolutionary War.

Rhode Island medical journal (2013)·2026
Same journal

New HIV Diagnoses Among Hispanic/Latino Men Who Have Sex with Men, 2010-2024, Rhode Island.

Rhode Island medical journal (2013)·2026
Same journal

Improving Health Equity Training with an Integrated Simulation-Based Curriculum.

Rhode Island medical journal (2013)·2026
Same journal

Interpreter Use in an Academic Pediatric Hospital.

Rhode Island medical journal (2013)·2026
Same journal

Impact of Acute, Major Infrastructure Failure on Emergency Medical Service Transport Times in Rhode Island.

Rhode Island medical journal (2013)·2026
Same journal

Developing an Automated Text Message Program in the Emergency Department.

Rhode Island medical journal (2013)·2026
See all related articles

Related Experiment Video

Updated: Aug 8, 2025

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

28

Statewide Variation in Cannabinoid Regulations.

Katherine Stewart1, Vinald Francis2, Rachel S Wightman3

  • 1PGY3, Department of Emergency Medicine, Warren Alpert Medical School of Brown University.

Rhode Island Medical Journal (2013)
|February 27, 2023
PubMed
Summary
This summary is machine-generated.

State cannabis regulations vary widely, impacting product THC:CBD ratios, limits, and testing. This lack of centralized data hinders consumer transparency and understanding of cannabinoid products.

Keywords:
cannabiscannabis potencycannabis regulation

More Related Videos

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

243
Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

6.2K

Related Experiment Videos

Last Updated: Aug 8, 2025

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

28
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

243
Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

6.2K

Area of Science:

  • Public Health
  • Regulatory Science
  • Pharmacology

Background:

  • Increasing state-level legalization of cannabinoids for medical and non-medical use.
  • Significant knowledge gaps exist regarding appropriate dosing, health impacts, and regulatory frameworks for cannabis products.
  • The evolving landscape necessitates a clear understanding of current state regulations.

Purpose of the Study:

  • To summarize and evaluate 2022 state-specific cannabis regulations.
  • To assess the presence and variability of THC:CBD ratios, maximum THC content, possession limits, and testing requirements for cannabinoid content and contaminants.
  • To highlight inconsistencies in cannabis product regulation across the United States.

Main Methods:

  • Analysis of 2022 state cannabis regulations.
  • Evaluation of data for THC:CBD ratios, maximum THC concentration, possession limits, and mandatory testing for cannabinoids and contaminants (pesticides, heavy metals).
  • Presentation of findings using comparative maps and tables.

Main Results:

  • Substantial variation observed in product THC content, purchasing limits, and quality control measures across states.
  • Inconsistent requirements for cannabinoid ratios and contaminant testing.
  • Significant differences in state-level regulations for cannabis products.

Conclusions:

  • The current regulatory landscape for cannabis products exhibits considerable heterogeneity nationwide.
  • A lack of centralized data collection and transparency exists between states and consumers.
  • Further standardization and data sharing are needed to ensure consumer safety and informed use of cannabinoid products.